Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis

NCT04158843 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2020-05-12

No results posted yet for this study

Summary

A Randomized, Open Label, Phase III Trial to Evaluate Radical Local Treatment versus Palliative Treatment for Breast Cancer Patients with Primary Ipsilateral Humerus or Sternum Oligometastasis

Conditions

Interventions

PROCEDURE

Radical resection

Radical resection is performed, and the cutting edge is negative.

RADIATION

Radical radiotherapy

Radical local radiotherapy is feasible (cumulative radiotherapy dose is greater than or equal to 50Gy).

OTHER

Palliative treatment

Including palliative internal fixation, radiotherapy, systemic chemotherapy, endocrine therapy or targeted therapy

Sponsors & Collaborators

  • xuexin he

    lead OTHER

Principal Investigators

  • Xiaobo Yan, MD · The Second Affiliated Hospital of Zhejiang University School of Medicidne

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-09
Primary Completion
2022-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04158843 on ClinicalTrials.gov